Onset of neurologic deficits after treatment with dihydroergotamine in a patient with sagittal sinus thrombosis

Clinical Neuropharmacology

Volumn 19, Issue 2, 1996, Pages 177-184

  Steven Evans, M ^a   Naritoku, Dean K ^a   Couch, James R ^a   Ghobrial, Mona W ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Dihydroergotamine; Migraine; Stroke; Thrombosis

Indexed keywords

AMITRIPTYLINE; CODEINE; DEXAMETHASONE; DIHYDROERGOTAMINE; MANNITOL; MESTRANOL PLUS NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PENTOBARBITAL; PROCHLORPERAZINE; PROMETHAZINE;

ADULT; ARTICLE; BABINSKI REFLEX; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; BRAIN INFARCTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FATALITY; FEMALE; HEADACHE; HUMAN; INTRACRANIAL HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MIGRAINE; MUSCLE WEAKNESS; NAUSEA; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; ORAL DRUG ADMINISTRATION; PAPILLEDEMA; PRIORITY JOURNAL; SUPERIOR SAGITTAL SINUS;

EID: 9044237680     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199619020-00007     Document Type: Article

References (22)

1. Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986;36:995-7.
2. Silberstein SD, Schulman EA, Hopkins MM. Repetitive intravenous DHE in the treatment of refractory headache. Headache 1990;30:334-9.
3. Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache 1986;26:168-71.
4. Belgrade MJ, Ling LJ, Schleevogt MB, Ettinger MG, Ruiz E. Comparison of single dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache. Neurology 1989;39:590-2.
5. Goldfischer JD. Acute myocardial infarction secondary to ergot therapy: report of a case and review of the literature. N Engl J Med 1960;262:860-3.
6. Saper JR. Headache disorders: current concepts and treatment strategies. Littleton, MA: Wright, PSG, 1983.
7. Schulman EA, Rosenberg SB. Claudication: an unusual side effect of DHE administration. Headache 1991;31:237-9.
8. Iffy L, TenHove W, Frisoli G. Acute myocardial infarction in the puerperium in patients receiving bromocriptine. Am J Obstet Gynecol 1986;155:371-2.
9. Ruch A, Duhring JL. Postpartum myocardial infarction in a patient receiving bromocriptine. Obstet Gynecol 1989;74(3 Pt 2):448-51.
10. Maurel C, Abhay K, Schaeffer A, Lange F, Castot A, Melon E. Acute thrombotic accident in the postpartum period in a patient receiving bromocriptine. Crit Care Med 1990;18:1180-1.
11. Anonymous. Imitrex (sumatriptan succinate) product information. Cerenex Pharmaceuticals, Inc., Research Triangle Park, NC, 1994.
12. Muller-Schweinitzer E, Rosenthaler J. Dihydroergotamine: pharmacokinetics, pharmacodynamics. and mechanism of venoconstrictor action in beagle dogs. J Cardiovasc Pharmacol 1987;9:686-93.
13. Aellig WH. Investigation of the venoconstrictor effect of 8-hydroxydihydroergotamine, the main metabolite of dihydroergotamine in man. Eur J Clin Pharmacol 1984;26:239-42.
14. Bousser MG, Chilas J, Bories J, Castaigne P. Cerebral venous thrombosis - a review of 38 cases. Stroke 1985;16:199-213.
15. Lee TJ-F. Recent studies on serotonin-containing fibers in cerebral circulation. In: Seylaz J, Sercombe R, eds. Neurotransmission and cerebrovascular function II. Amsterdam: Elsevier, 1989:133-49.
16. Comerota AJ, White JV. The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis. Chest 1986;89(5 suppl):389S-95S.
17. Gent M, Roberts RS. A meta-analysis of the studies of dihydroergotamine plus heparin in the prophylaxis of deep vein thrombosis. Chest 1986;89(5 suppl):396S-400S.
18. Schlag G, Poingenfurst J, Gaudernak T. Risk/benefit of heparin-dihydroergotamine thromboembolic prophylaxis [Letter]. Lancet 1986;2(8521-22):1465.
19. Cuypers J, Matakas F, Potolicchio SJ Jr. Effect of central venous pressure on brain tissue pressure and brain volume. J Neurosurg 1976;45:89-94.
20. Gjerris F, Soelberg Sorensen P, Vorstrup S, Paulson OB. Intracranial pressure, conductance to cerebrospinal fluid outflow, and cerebral blood How patients with benign intracranial hypertension (pseudotumor cerebri). Ann Neurol 1985;17:158-62.
21. Grande PO. The effects of dihydroergotamine in patients with head injury and raised intracranial pressure. Intensive Care Med 1989;15:523-7.
22. Beretta L. Dihydroergotamine and intracranial pressure [Letter]. Intensive Care Med 1990;16:347.